Global Point of Care

NMP22™ BladderChek™

The NMP22™ BladderChek™ Test is a fast, easy to use and non-invasive test that aids in the diagnosis and monitoring of bladder cancer, in conjunction with standard diagnostic procedures. With results in 30 minutes at the point-of-care, results can be delivered to patients during the same office visit, allowing a rapid and cost-effective aid in the detection of bladder cancer in patients at risk.

NMP22 BladderChek NMP22 BladderChek NMP22 BladderChek

VIEW REFERENCES

  1. Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA. 2006;295(3):299-305. doi:10.1001/jama.295.3.299
  2. Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005;293(7):810-816. doi:10.1001/jama.293.7.810
  3. Kumar A, Kumar R, Gupta N. Comparison of NMP22 BladderChek Test and Urine Cytology for the Detection of Recurrent Bladder Cancer. Jpn. J. Clin. Oncol. 2006: 36(3) 172-175. https://doi.org/10.1093/jjco/hyi244